Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Mar:40:100638.
doi: 10.1016/j.blre.2019.100638. Epub 2019 Nov 6.

Thrombocytopenia in pregnancy: Diagnosis and approach to management

Affiliations
Review

Thrombocytopenia in pregnancy: Diagnosis and approach to management

Allyson M Pishko et al. Blood Rev. 2020 Mar.

Abstract

Thrombocytopenia during pregnancy presents unique challenges for the hematologist. Obstetricians generally manage many of the pregnancy-specific etiologies, ranging from the benign (gestational thrombocytopenia) to the life-threatening (preeclampsia; hemolysis, elevated liver enzymes and low platelets syndrome; and acute fatty liver of pregnancy). However, hematologists may be consulted for atypical and severe presentations and to help manage non-pregnancy specific etiologies, including immune thrombocytopenia, thrombotic thrombocytopenic purpura, hemolytic uremic syndrome and antiphospholipid syndrome, among others, in which maternal and fetal risks must be considered. This review provides a general approach to the diagnosis and management of thrombocytopenia in pregnancy for the consulting hematologist.

Keywords: Gestational thrombocytopenia; Hemolytic uremic syndrome; Immune thrombocytopenia; Preeclampsia; Pregnancy; Thrombocytopenia; Thrombotic thrombocytopenic purpura; von Willebrand disease.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest AP has received an educational grant from Novo Nordisk Inc. DC has served as a consultant or advisory board member for Amgen, Rigel, Novartis, Dova, and CSL has received research support from T2Biosystems, Aplagon, Syntimmune, and Momenta. The other authors have no conflicts to declare.

Publication types

LinkOut - more resources